Company Filing History:

15 out of 574

Ono Pharmaceutical Co., Ltd.

patents

2 out of 3,472

Toray Industries, Inc.

patents

1 out of 22

Ono Pharmaceuticals Co., Ltd.

patents

Years Active: 1994-2005

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6924307 - Aminobutyric acid derivatives and pharmaceutical composition containing the same as active ingredient (2005-08-02),

2. 6569899 - 4-aminobutanoic acid derivatives and drugs containing these derivatives as the active ingredient (2003-05-27),

3. 6420427 - Aminobutyric acid derivatives (2002-07-16),

4. 6300514 - Aryl (sulfide, sulfoxide and sulfone) derivatives and drugs containing the same as the active ingredient (2001-10-09),

5. 6086869 - Use of interferon-.beta. or .gamma. to treat retinal edema (2000-07-11),

6. 5962439 - Fused benzeneoxyacetic acid derivatives (1999-10-05),

7. 5935985 - Phenoxyacetic acid derivatives (1999-08-10),

8. 5849919 - Fused benzeneoxyacetic acid derivatives which have PGI.sub.2 receptor (1998-12-15),

9. 5721206 - Pharmaceutical composition for use as a retinal pigment epithelial cell (1998-02-24),

10. 5703099 - Phenoxyacetic acid derivatives (1997-12-30),

11. 5596009 - Fused benzeneoxyacetic acid derivatives (1997-01-21),

12. 5589496 - Fused benzeneoxyacetic acid derivatives which have PGI.sub.2 receptor (1996-12-31),

13. 5536736 - Triazolyl-phenoxyacetic acid compounds which have useful pharmaceutical (1996-07-16),

14. 5480998 - Oxime derivative (1996-01-02),

15. 5461045 - Fused benzeneoxyacetic acid derivatives (1995-10-24),

Title: The Innovative Contributions of Kanji Takahashi

Introduction

Kanji Takahashi is a renowned inventor based in Osaka, Japan, with an impressive portfolio of 18 patents. His work primarily focuses on pharmaceutical compositions, particularly those that offer innovative solutions to various medical issues.

Latest Patents

Among his latest patents, Kanji Takahashi has made significant strides with his invention related to amino butyric acid derivatives and pharmaceutical compositions containing these derivatives as active ingredients. These derivatives, characterized by the formula (I) outlined in his specifications, showcase non-toxic salts that inhibit matrix metalloproteinase. This groundbreaking research positions the compounds as beneficial for the prevention and treatment of a range of diseases, including rheumatoid diseases, osteoarthritis, osteoporosis, periodontitis, and various forms of cancer.

Career Highlights

Throughout his career, Kanji has collaborated with notable companies, such as Ono Pharmaceutical Co., Ltd. and Toray Industries, Inc. His professional journey highlights a deep commitment to developing innovative therapeutic solutions that address complex medical challenges.

Collaborations

In his quest for innovation, Kanji has worked alongside respected professionals, including Nobuyuki Hamanaka and Hidekado Tokumoto. Their collective expertise has fostered advancements in the pharmaceutical field, contributing significantly to health sciences.

Conclusion

Kanji Takahashi stands out as a remarkable inventor whose contributions to medical science have the potential to change lives. His dedication to developing effective pharmaceutical solutions and his collaborative spirit underscore his important role in the landscape of innovation and invention in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent (CIPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.